# PAVmed Inc.: filings

PAVM · Nasdaq · CIK 1624326 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pavm.md) · [Financials](/companies/pavm/financials.md) · [Filings](/companies/pavm/filings.md) · [Insiders](/companies/pavm/insiders.md)

## Reports and events: 282 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 186, 4 144, 10-Q 32, 3 21, CORRESP 21, UPLOAD 20, S-1/A 17, S-8 17, 424B3 15, 424B5 15, DEF 14A 15, EFFECT 14, 10-K 11, PRE 14A 11, S-3 10, D 9, DEFA14A 8, SCHEDULE 13G 8, SC 13G 7, SCHEDULE 13G/A 7, SC TO-I/A 7, FWP 6, S-3/A 6, SC 13D/A 6, S-1 5, SC 13G/A 5, 10-K/A 4, 144 4, 5 4, NT 10-Q 4, SC TO-C 4, 10-Q/A 3, 25-NSE 3, ARS 3, NT 10-K 3, 8-A12B 2, SC TO-I 2, 3/A 1, 424B4 1, 4/A 1, 8-K/A 1, CERT 1, CERTNAS 1, D/A 1, DEF 14C 1, DEL AM 1, DRS 1, DRS/A 1, DRSLTR 1, PRE 14C 1, RW 1, S-3MEF 1, S-4 1, SC 13D 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 21:28 ET | [8-K](/filings/0001493152-26-048138.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001493152-26-048138 |
| 2026-09-10 | 23:15 ET | [8-K](/filings/0001493152-26-042021.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-042021 |
| 2026-08-14 | 14:44 ET | [8-K](/filings/0001493152-26-038072.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-038072 |
| 2026-08-13 | 21:03 ET | [10-Q](/filings/0001437749-26-027733.md) | Quarterly report, period 2026-06-30 | 0001437749-26-027733 |
| 2026-06-24 | 21:00 ET | [8-K](/filings/0001493152-26-029944.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-029944 |
| 2026-05-15 | 12:05 ET | [8-K](/filings/0001493152-26-023352.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-023352 |
| 2026-05-14 | 21:17 ET | [10-Q](/filings/0001437749-26-017121.md) | Quarterly report, period 2026-03-31 | 0001437749-26-017121 |
| 2026-04-30 | 13:28 ET | [DEF 14A](/filings/0001493152-26-020705.md) | Proxy statement, period 2026-04-30 | 0001493152-26-020705 |
| 2026-04-09 | 00:56 ET | [SCHEDULE 13D](/filings/0001094891-26-000179.md) | Ownership report, active investor | 0001094891-26-000179 |
| 2026-03-30 | 12:10 ET | [8-K](/filings/0001493152-26-013477.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-013477 |
| 2026-03-27 | 21:15 ET | [8-K](/filings/0001493152-26-013264.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-013264 |
| 2026-03-27 | 21:08 ET | [10-K](/filings/0001437749-26-010115.md) | Annual report, period 2025-12-31 | 0001437749-26-010115 |
| 2026-02-24 | 21:15 ET | [DEF 14A](/filings/0001493152-26-007884.md) | Proxy statement, period 2026-02-24 | 0001493152-26-007884 |
| 2026-02-04 | 13:12 ET | [8-K](/filings/0001493152-26-005023.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-005023 |
| 2026-01-23 | 21:30 ET | [8-K](/filings/0001493152-26-003409.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-003409 |
| 2025-12-30 | 14:00 ET | [8-K](/filings/0001493152-25-029510.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-029510 |
| 2025-12-05 | 21:15 ET | [8-K](/filings/0001493152-25-026368.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-026368 |
| 2025-11-13 | 13:00 ET | [8-K](/filings/0001493152-25-022122.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-022122 |
| 2025-11-12 | 22:23 ET | [10-Q](/filings/0001493152-25-022017.md) | Quarterly report, period 2025-09-30 | 0001493152-25-022017 |
| 2025-10-31 | 20:05 ET | [DEF 14A](/filings/0001493152-25-020379.md) | Proxy statement, period 2025-10-31 | 0001493152-25-020379 |
| 2025-09-11 | 13:28 ET | [8-K](/filings/0001493152-25-013048.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-013048 |
| 2025-08-14 | 12:00 ET | [8-K](/filings/0001641172-25-023729.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-023729 |
| 2025-08-14 | 00:04 ET | [10-Q](/filings/0001493152-25-011923.md) | Quarterly report, period 2025-06-30 | 0001493152-25-011923 |
| 2025-07-30 | 12:00 ET | [8-K](/filings/0001493152-25-011491.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-011491 |
| 2025-06-24 | 12:15 ET | [8-K](/filings/0001641172-25-016227.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-016227 |
| 2025-06-18 | 21:00 ET | [8-K](/filings/0001641172-25-015612.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-015612 |
| 2025-05-15 | 12:25 ET | [8-K](/filings/0001641172-25-010536.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-010536 |
| 2025-05-15 | 01:32 ET | [10-Q](/filings/0001641172-25-010433.md) | Quarterly report, period 2025-03-31 | 0001641172-25-010433 |
| 2025-04-30 | 20:15 ET | [DEF 14A](/filings/0001641172-25-007773.md) | Proxy statement, period 2025-04-30 | 0001641172-25-007773 |
| 2025-04-25 | 20:52 ET | [8-K](/filings/0001641172-25-006250.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-006250 |
| 2025-04-17 | 21:12 ET | [8-K](/filings/0001641172-25-005279.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-005279 |
| 2025-04-11 | 13:27 ET | [8-K](/filings/0001641172-25-003741.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-003741 |
| 2025-03-25 | 12:15 ET | [8-K](/filings/0001641172-25-000517.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-000517 |
| 2025-03-24 | 21:22 ET | [10-K](/filings/0001641172-25-000364.md) | Annual report, period 2024-12-31 | 0001641172-25-000364 |
| 2025-03-10 | 20:15 ET | [8-K](/filings/0001493152-25-009698.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-009698 |
| 2025-02-21 | 22:00 ET | [8-K](/filings/0001493152-25-007902.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-007902 |
| 2025-02-18 | 13:30 ET | [8-K](/filings/0001493152-25-007094.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-007094 |
| 2025-01-24 | 22:15 ET | [8-K](/filings/0001493152-25-003631.md) | 3.01 Delisting notice; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001493152-25-003631 |
| 2025-01-21 | 21:30 ET | [8-K](/filings/0001493152-25-003053.md) | 3.01 Delisting notice; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-003053 |
| 2025-01-15 | 21:45 ET | [8-K](/filings/0001493152-25-002398.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-002398 |
| 2024-12-06 | 21:15 ET | [DEF 14A](/filings/0001493152-24-049070.md) | Proxy statement, period 2024-12-06 | 0001493152-24-049070 |
| 2024-11-29 | 21:21 ET | [8-K](/filings/0001493152-24-048173.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001493152-24-048173 |
| 2024-11-21 | 21:30 ET | [8-K](/filings/0001493152-24-047156.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001493152-24-047156 |
| 2024-11-14 | 13:15 ET | [8-K](/filings/0001493152-24-045362.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-045362 |
| 2024-11-14 | 02:29 ET | [10-Q](/filings/0001493152-24-045258.md) | Quarterly report, period 2024-09-30 | 0001493152-24-045258 |
| 2024-09-16 | 20:05 ET | [8-K](/filings/0001493152-24-036380.md) | 2.01 Completion of an acquisition or disposition; 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-036380 |
| 2024-08-13 | 12:18 ET | [8-K](/filings/0001493152-24-031471.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-031471 |
| 2024-08-12 | 20:08 ET | [10-Q](/filings/0001493152-24-031268.md) | Quarterly report, period 2024-06-30 | 0001493152-24-031268 |
| 2024-06-20 | 21:00 ET | [8-K](/filings/0001493152-24-024540.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-024540 |
| 2024-05-14 | 14:38 ET | [8-K](/filings/0001493152-24-019117.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-019117 |

Page 1 of 6. [Older](/companies/pavm/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.